Jeffrey J. Katke

Jeffrey was founder and CEO of Metagenics Inc., a nutrigenomics and lifestyle medicine company, from 1983 to 2010. Under his leadership, the company expanded internationally with manufacturing and distribution facilities in 46 countries. During Jeff’s tenure, Metagenics employed over 1,000 people and offered over 1,200 products to more than 75,000 healthcare providers and millions of consumers. In 2009, Jeffrey sold Metagenics.

He is an investor in Kindex Therapeutics, a biotech spin-off from Metagenics, and serves on that company’s board of directors. In 2010 Mr. Katke founded Katke Holdings LLC to make private equity investments in early stage growth businesses. Through Katke Holdings LLC, Jeffrey is one of the principals of Avistone LLC, a commercial real estate investment company, Intefusion LLC, a medical insurance billing company, and JCK Designs LLC, a residential real estate investment company. Mr. Katke serves as Chairman for each company and provides management consulting.

He is actively involved in two Christian philanthropic programs, Blessing of the Father Ministries, which is focused on helping orphans, widows and broken families and Harbor Hope Center, serving homeless students and those facing hunger and other life crises, where he serves as President.

His areas of expertise include: executive management, strategic planning, operations, financial review and reporting and regulatory compliance.